Literature DB >> 8536633

Estrogen and progesterone receptors, cell proliferation, and c-fos expression in the ovine uterus during early pregnancy.

J Zheng1, M L Johnson, D A Redmer, L P Reynolds.   

Abstract

To evaluate uterine growth during pregnancy and the potential roles of estrogen and progesterone in regulating uterine cell proliferation and c-fos expression, ewes were assigned randomly to slaughter on day 12 after estrus (nonpregnant, NP), and on days 12, 18, 24, or 30 after mating (pregnant, P) in Exp 1 (n = 7 ewes/day) and on days 12 or 14 after estrus and on days 12, 14, 16, 18, 21, or 24 after mating in Exp 2 (n = 3-6 ewes/day). In Exp 1, endometrial expression of c-fos mRNA was evaluated, and labeling index was determined both in vitro (incorporation of 3H-thymidine) and in vivo (iv injection of bromodeoyxuridine [BrdU], a thymidine analog). Endometrial expression of the c-fos proto-oncogene was increased by approximately 10-fold on days 18, 24, and 30 P compared with day 12 NP or P. Labeling index (proportion of cells incorporating 3H-thymidine or BrdU, which provides an index of the rate of cell proliferation) of endometrial caruncular and intercaruncular tissues was low for day 12 NP or P, increased on day 18 P, and remained elevated on days 24 P and 30 P. On day 18 P, labeling index also was greater for gravid than nongravid horns for both caruncular and intercaruncular tissues. In Exp 2, estrogen receptors (ER), progesterone receptors (PR), and proliferating (BrdU-positive) cells were immunolocalized. The percentage of cells exhibiting specific staining for ER, PR, and BrdU was quantified morphometrically for epithelial, stromal, and glandular tissues within luminal and deep regions, as well as for myometrial tissues. For luminal epithelium and glands, the rate of cell proliferation increased dramatically by day 18 P, even though ER and PR levels were low in these compartments. Conversely, the rate of cell proliferation remained low throughout early pregnancy in deep glands, deep stroma, and myometrium, in association with sustained or transient increases in ER and PR levels. For luminal stroma, the rate of cell proliferation increased by day 21 P even though ER levels were low and PR levels remained high. Thus, during early pregnancy, c-fos expression increased concomitantly with increased endometrial cell proliferation. In addition, during early pregnancy, ER and PR levels were inversely related to the rate of cell proliferation in most of the uterine tissue compartments except luminal stroma, which exhibited increased cell proliferation even though ER levels were low and PR levels remained high.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8536633     DOI: 10.1210/endo.137.1.8536633

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Endometrial epithelial cell modifications in response to embryonic signals in bonnet monkeys (Macaca radiata).

Authors:  Shruti Nimbkar-Joshi; Rajendraprasad R Katkam; Uddhav K Chaudhari; Sheeba Jacob; Dhananjay D Manjramkar; Sidhhanath M Metkari; Indira Hinduja; Vijay Mangoli; Sadhana Desai; Sanjeeva D Kholkute; Chander P Puri; Geetanjali Sachdeva
Journal:  Histochem Cell Biol       Date:  2012-04-24       Impact factor: 4.304

2.  Endothelial vasodilator production by ovine uterine and systemic arteries: ovarian steroid and pregnancy control of ERalpha and ERbeta levels.

Authors:  Michael J Byers; Amy Zangl; Terrance M Phernetton; Gladys Lopez; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

3.  Placental development during early pregnancy in sheep: Progesterone and estrogen receptor protein expression.

Authors:  Soumi Bairagi; Anna T Grazul-Bilska; Pawel P Borowicz; Arshi Reyaz; Veselina Valkov; Lawrence P Reynolds
Journal:  Theriogenology       Date:  2018-04-07       Impact factor: 2.740

4.  Placental development during early pregnancy in sheep: effects of embryo origin on fetal and placental growth and global methylation.

Authors:  Anna T Grazul-Bilska; Mary Lynn Johnson; Pawel P Borowicz; Loren Baranko; Dale A Redmer; Lawrence P Reynolds
Journal:  Theriogenology       Date:  2012-10-30       Impact factor: 2.740

5.  Prion (PrPC) expression in ovine uteroplacental tissues increases after estrogen treatment of ovariectomized ewes and during early pregnancy.

Authors:  Mary Lynn Johnson; Anna T Grazul-Bilska; Lawrence P Reynolds; Dale A Redmer
Journal:  Reproduction       Date:  2014-03-24       Impact factor: 3.906

6.  Quantitative morphological changes in the interplacentomal wall of the gravid uterine horn of cattle during pregnancy.

Authors:  Rose M Albers; Anke Schnapper; Martin Beyerbach; Alois Boos
Journal:  Reprod Biol Endocrinol       Date:  2015-04-18       Impact factor: 5.211

7.  Effects of estradiol-17beta on expression of mRNA for seven angiogenic factors and their receptors in the endometrium of ovariectomized (OVX) ewes.

Authors:  Mary Lynn Johnson; Anna T Grazul-Bilska; Dale A Redmer; Lawrence P Reynolds
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

8.  Nephroprotective effect of estrogen and progesterone combination on cisplatin-induced nephrotoxicity in ovariectomized female rats.

Authors:  M Ghasemi; M Nematbakhsh; Z Pezeshki; N Soltani; M Moeini; A Talebi
Journal:  Indian J Nephrol       Date:  2016 May-Jun

9.  Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology.

Authors:  Joanna H Sier; Alfred E Thumser; Nick J Plant
Journal:  BMC Syst Biol       Date:  2017-12-15

10.  MUFINS: multi-formalism interaction network simulator.

Authors:  Huihai Wu; Axel von Kamp; Vytautas Leoncikas; Wataru Mori; Nilgun Sahin; Albert Gevorgyan; Catherine Linley; Marek Grabowski; Ahmad A Mannan; Nicholas Stoy; Graham R Stewart; Lara T Ward; David J M Lewis; Jacek Sroka; Hiroshi Matsuno; Steffen Klamt; Hans V Westerhoff; Johnjoe McFadden; Nicholas J Plant; Andrzej M Kierzek
Journal:  NPJ Syst Biol Appl       Date:  2016-11-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.